Lincoln Pharmaceuticals Share Price
Know More₹565.00-1.60 (-0.28%)
04:01 PM, 7-Mar-2025₹566.05 3.75 (0.67%)
03:47 PM, 7-Mar-2025BSE : 531633
NSE : LINCOLN
Sector : Health care
ISIN Code : INE405C01035
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 07-Mar-2025 | 10:31 AM IST
| Market Cap (₹ Cr) | 1,132 |
Traded Value (₹ Cr) | 0.15 |
Volume (Shares) | 2,660 |
Face Value (₹) | 10 |
52-Week High (₹) | 975.00 |
52-Week High Date | 09-Dec-2024 |
52-Week Low (₹) | 498.00 |
52-Week Low Date | 05-Jun-2024 |
All Time High (₹) | 975.00 |
All Time High Date | 09-Dec-2024 |
All Time Low (₹) | 8.05 |
All Time Low Date | 12-Jun-2002 |
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd News
Lincoln Pharma. Announcement
Lincoln Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,134 |
| EPS - TTM (₹) [C] | 44.62 |
| P/E Ratio (X) [C] | 12.69 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 18.00 |
| Latest Dividend Date | 13-Sep-2024 |
| Dividend Yield (%) | 0.32 |
| Book Value Share (₹) [C] | 319.16 |
| P/B Ratio (₹) [C] | 1.77 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.01 | 219 | 0.04 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 560.05 574.70 |
| Week Low/High (₹) | 499.00 576.00 |
| Month Low/High (₹) | 499.00 778.00 |
| Year Low/High (₹) | 499.00 980.00 |
| All time Low/High (₹) | 8.05 980.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 8.77% | 8.64% | 1.55% | 1.93% |
| 1 Month | -24.51% | -24.44% | -4.53% | -4.28% |
| 3 Month | -38.47% | -38.43% | -9.03% | -8.61% |
| 6 Month | -26.77% | -26.75% | -8.44% | -9.25% |
| 1 Year | -11.46% | -11.42% | 0.29% | 0.26% |
| 3 Year | 87.50% | 87.68% | 40.67% | 42.17% |
Company Info
Company Information
Chairman (Non-Executive) : Kishorbhai M Shah
Managing Director : Mahendra G Patel
Whole-time Director : Hasmukhbhai I Patel
Whole-time Director : Munjal Mahendrabhai Patel
Whole-time Director : Aashish R Patel
Independent Director : Saurin J Parikh
Non Executive Director : Rajnikant G Patel
Company Sec. & Compli. Officer : Trusha Shah
Independent Director : Seema Mehta
Independent Director : Nareshkumar Pirabhai Suthar
Registered Office: Lincoln House B/H Satyam Compe, Science City Road Sola,Ahmedabad,Gujarat-380060 Ph: 91-079-67778000
FAQs about Lincoln Pharmaceuticals Ltd
1. What's the Lincoln Pharmaceuticals Ltd share price today?
Lincoln Pharmaceuticals Ltd share price was Rs 565.00 at 04:01 PM IST on 7th Mar 2025. Lincoln Pharmaceuticals Ltd share price was up by 0.28% over the previous closing price of Rs 566.60. Lincoln Pharmaceuticals Ltd share price trend:
- Last 1 Month: Lincoln Pharmaceuticals Ltd share price moved down by 24.51% on BSE.
- Last 3 Months: Lincoln Pharmaceuticals Ltd share price moved down by 38.47% on BSE.
- Last 12 Months: Lincoln Pharmaceuticals Ltd share price moved down by 11.46% on BSE.
- Last 3 Years: Lincoln Pharmaceuticals Ltd share price moved up by 87.50% on BSE.
2. How can I quickly analyse the performance of the Lincoln Pharmaceuticals Ltd stock?
The performance of the Lincoln Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 12.69
- Price to book value ratio is 1.77
- Dividend yield of 0.32
- The EPS (trailing 12 months) of the Lincoln Pharmaceuticals Ltd stock is Rs 44.62
3. What is the market cap of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd has a market capitalisation of Rs 1,132 crore.
4. What is Lincoln Pharmaceuticals Ltd's 52-week high/low share price?
The Lincoln Pharmaceuticals Ltd’s 52-week high share price is Rs 975.00 and 52-week low share price is Rs 498.00.
5. Is the Lincoln Pharmaceuticals Ltd profitable?
On a consolidated basis, Lincoln Pharmaceuticals Ltd reported a profit of Rs 20.77 crore on a total income of Rs 155.52 crore for the quarter ended 2024. For the year ended Dec 2024, Lincoln Pharmaceuticals Ltd had posted a profit of Rs 20.77 crore on a total income of Rs 155.52 crore.
6. Which are Lincoln Pharmaceuticals Ltd’s peers in the Health care sector?
Lincoln Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Sigachi Indust., Bliss GVS Pharma, Hester Bios, Lincoln Pharma., Shukra Pharma., Shree Ganesh Rem, Kopran.
7. Who owns how much in Lincoln Pharmaceuticals Ltd?
Key changes to the Lincoln Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Lincoln Pharmaceuticals Ltd has gone up to 49.78 per cent as of Dec 2024 from 49.53 per cent as of Mar 2024.
- Indian Public holding in Lincoln Pharmaceuticals Ltd has gone down to 36.71 per cent as of Dec 2024 from 37.36 per cent as of Mar 2024.
- Non Institutional Investors holding in Lincoln Pharmaceuticals Ltd has gone down to 8.35 per cent as of Dec 2024 from 9.13 per cent as of Mar 2024.
- Foreign Institutional Investors holding in Lincoln Pharmaceuticals Ltd has gone up to 5.16 per cent as of Dec 2024 from 3.93 per cent as of Mar 2024.
- Other Institutional Investors holding in Lincoln Pharmaceuticals Ltd has gone down to 0.00 per cent as of Dec 2024 from 0.05 per cent as of Mar 2024.
